Skip to content
10-Q/A

Quarterly Report

Eastgate Biotech Corp

0001640334-18-000405

← back to feed
Filed
Mar 1, 2018 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Feb 27, 2018 934.31M sh
Cash And Equivalents Q1 2016 · Mar 31, 2016 $10.82K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $19.24K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $28.86K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $286.48K
Stockholders Equity restated Q1 2016 · Mar 31, 2016 −$3.21M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$2.48M
Stockholders Equity Q1 2016 · Dec 31, 2014 −$1.4M
Current Liabilities restated Q1 2016 · Mar 31, 2016 $3.17M
Current Liabilities Q1 2016 · Dec 31, 2015 $2.73M
Total Liabilities restated Q1 2016 · Mar 31, 2016 $3.22M
Total Liabilities Q1 2016 · Dec 31, 2015 $2.78M
Current Assets restated Q1 2016 · Mar 31, 2016 $10.82K
Current Assets Q1 2016 · Dec 31, 2015 $113.52K
Total Assets restated Q1 2016 · Mar 31, 2016 $10.82K
Total Assets Q1 2016 · Dec 31, 2015 $297.92K
Sga Expense restated Q1 2016 · Mar 31, 2016 $1.03M
Sga Expense Q1 2016 · Mar 31, 2015 $1.05M
Rd Expense restated Q1 2016 · Mar 31, 2016 $138.64K
Rd Expense Q1 2016 · Mar 31, 2015 $396.12K
Net Income restated Q1 2016 · Mar 31, 2016 −$1.46M
Net Income Q1 2016 · Mar 31, 2015 −$1.79M
Operating Income restated Q1 2016 · Mar 31, 2016 −$1.24M
Operating Income Q1 2016 · Mar 31, 2015 −$1.77M